# Lubiprostone for Children With Constipation

> **NCT02138136** · PHASE3 · COMPLETED · sponsor: **Sucampo Pharma Americas, LLC** · enrollment: 419 (actual)

## Conditions studied

- Constipation - Functional

## Interventions

- **DRUG:** Lubiprostone

## Key facts

- **NCT ID:** NCT02138136
- **Lead sponsor:** Sucampo Pharma Americas, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-26
- **Primary completion:** 2017-05-01
- **Final completion:** 2017-05-01
- **Target enrollment:** 419 (ACTUAL)
- **Last updated:** 2020-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02138136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02138136, "Lubiprostone for Children With Constipation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02138136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*